friedelinol has been researched along with Breast Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cerqueira, F; FlorĂȘncio, MH; Justino, F; Marcelo-Curto, MJ; Moiteiro, C; Nascimento, MS; Pedro, M; Pinto, MM; Tavares, R | 1 |
He, Y; Hong, L; Jiang, Z; Pan, Z; Zhang, J; Zhao, Y; Zhou, Y | 1 |
2 other study(ies) available for friedelinol and Breast Neoplasms
Article | Year |
---|---|
Synthetic secofriedelane and friedelane derivatives as inhibitors of human lymphocyte proliferation and growth of human cancer cell lines in vitro.
Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Breast Neoplasms; Chromatography, Thin Layer; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Kidney Neoplasms; Lung Neoplasms; Lymphocytes; Magnetic Resonance Spectroscopy; Melanoma; Molecular Structure; Oxidation-Reduction; Portugal; Quercus; Structure-Activity Relationship; Triterpenes; Tumor Cells, Cultured | 2001 |
Epifriedelinol Ameliorates DMBA-Induced Breast Cancer in Albino Rats by Regulating the PI3K/AKT Pathway.
Topics: Animals; Apoptosis; Breast Neoplasms; Female; Oleanolic Acid; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; RNA, Messenger | 2022 |